|

TG THERAPEUTICS INC (TGTX)

US88322Q1085 - Common Stock

15.72  -0.31 (-1.93%)

After market: 15.68 -0.04 (-0.25%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
189.80M2.79M6.69M150.00K150.00K
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
6.30M270.00K790.00KN/AN/A
Gross Profit
183.50M2.52M5.90MN/AN/A
Operating Expenses
202.30M195.35M350.67M273.75M169.21M
Research and Development
88.40M125.35M222.58M165.90M154.18M
Selling, General, and Administrative Expenses
114.10M70.01M128.09M107.85M15.03M
Operating Income
-19.00M-192.84M-344.77M-273.59M-169.06M
Interest Income/Expense
-13.00M-10.19M-5.64M-6.33M-5.29M
Other Income/Expense
6.10M4.70M2.31M540.00K1.47M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-25.90M-198.34M-348.10M-279.38M-172.87M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-25.90M-198.34M-348.10M-279.38M-172.87M
EBITDA
-18.76M-192.54M-344.49M-273.43M-168.96M
 
Per Share Data
EPS Diluted Total Ops
-0.28-1.46-2.63-2.42-1.96
Non GAAP EPS
-0.28-1.46-2.63-2.27-1.98
 
Statistics
Gross Profit Margin
96.68%90.32%88.19%N/AN/A
Profit Margin
-13.65%-7108.96%-5203.29%-186253.33%-115246.67%
Operating Profit Margin
-10.01%-6911.83%-5153.51%-182393.33%-112706.67%

All data in USD

Charts